<code id='C75F043707'></code><style id='C75F043707'></style>

<acronym id='C75F043707'></acronym>

<center id='C75F043707'><center id='C75F043707'><tfoot id='C75F043707'></tfoot></center><abbr id='C75F043707'><dir id='C75F043707'><tfoot id='C75F043707'></tfoot><noframes id='C75F043707'>

<optgroup id='C75F043707'><strike id='C75F043707'><sup id='C75F043707'></sup></strike><code id='C75F043707'></code></optgroup>

<b id='C75F043707'><label id='C75F043707'><select id='C75F043707'><dt id='C75F043707'><span id='C75F043707'></span></dt></select></label></b><u id='C75F043707'></u>

~~<i id='C75F043707'><strike id='C75F043707'><tt id='C75F043707'><pre id='C75F043707'></pre></tt></strike></i>~~

Home» leisure time» leisure time

leisure time

leisure time

author：hotspot 2025-10-02 08:11:07 Page View：3

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

advertisement

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cano Health’s bankruptcy is a warning for Medicare Advantage
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Problems with a popular proposal to regulate AI in health care

Problems with a popular proposal to regulate AI in health care

AdobeAsleadersacrossfederalagenciesswiftlyadvanceregulationsforAIinhealthcare,oneproposalnowseemstoo

Heart attack and stroke risk calculators need revising

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

What’s missing from the debate over nursing home staff minimums

TheCEOofaWashington,D.C.,seniorlivingfacilityhelpsaresidentbacktoherroom.NathanHoward/APTheBidenadmi

read more